This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Kaneka Corporation, National Center for Global Health and Medicine. Active years: 2023-2026.
Company Filing History:
2 out of 1,772 
2 out of 16 Years Active: 2023-2026
Title: Shigeharu Yabe: Innovator in Cell Therapy
Introduction
Shigeharu Yabe is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cell therapy, particularly in the production of pancreatic beta cells. His innovative work has led to the development of methods that enhance the therapeutic potential of somatic cells.
Latest Patents
Yabe holds 2 patents, with his latest inventions focusing on advanced methodologies in cell production. One of his notable patents is the "Method for Producing Pancreatic Beta Cells," which aims to create an endodermal cell population that is optimal for cell therapy preparations. This invention emphasizes reducing the proportion of undifferentiated cells, thereby improving the quality of somatic cells derived from the endodermal population. Another significant patent is the "Method for Producing Cell Population of Any of Three Germ Layers from Pluripotent Cell," which provides a framework for generating various cell types essential for therapeutic applications.
Career Highlights
Throughout his career, Shigeharu Yabe has worked with esteemed organizations such as Kaneka Corporation and the National Center for Global Health and Medicine. His experience in these institutions has allowed him to refine his expertise in cell therapy and contribute to groundbreaking research.
Collaborations
Yabe has collaborated with notable colleagues, including Hitoshi Okochi and Satsuki Fukuda. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of cell therapy.
Conclusion
Shigeharu Yabe's contributions to cell therapy through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in therapeutic applications, showcasing the importance of innovation in medical science.